Negotiating an international cannabis merger worth roughly $100 million is hard enough – but doing so during a global pandemic is downright daunting. That’s what Israel’s IM Cannabis had to do when it agreed in late 2020 to acquire To…
Middle East Cannabis Industry & Marijuana Business News
New marijuana REIT strikes deal to combine with Israel’s InterCure
Subversive Real Estate Acquisition REIT is combining with Israeli marijuana producer InterCure in a deal that values InterCure at $300 million and is intended to secure a Nasdaq listing for the combined company. InterCure’s Canndoc subsidiary is …
Israel lays out plan to legalize recreational cannabis, looking to Canada as a blueprint
Israel announced a road map to legalize cannabis potentially within one year and, in doing so, would create a regulated market for adult-use marijuana products largely based on Canada’s legalization model. The country’s justice minister, Av…
Global small-scale cannabis cultivation survey could offer business insights
An international survey aims to uncover new information about small-scale cannabis cultivation around the world, and the research team’s findings could provide valuable information for both commercial marijuana producers and businesses that serve…
Israel’s IM Cannabis applies for Nasdaq listing
IM Cannabis Corp, a multinational medical marijuana company headquartered in Israel, has applied to list its shares on the Nasdaq stock exchange. IM Cannabis (IMC) is looking to join a growing number of medical marijuana companies whose shares trade on…
Israel medical cannabis patient count hits record as imports soar
The number of authorized medical cannabis patients in Israel has more than doubled in the past two years – topping 70,000 – despite persistent supply and regulatory challenges, according to new data from the Israeli Medical Cannabis Agency …